Int J Gynaecol Obstet
Abdominal NeoplasmsLeiomyosarcomaMuscle Neoplasms
Dr. Mark W. Pasmantier, MD
NPI1558430199
- Medicare services, 2022
- 8,320
- Part D claims, 2024
- 24
- Publications
- 4
- Clinical trials
- 1
- Industry payments
- $1,901
- Practice address
- 407 E 70th St, New York, NY 10021-5311
- Practice phone
- Call (212) 517-5900
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Morton Coleman MD And Mark W Pasmantier
Medical specialty practice · New York, New York
Find Dr. Pasmantier's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark W. Pasmantier is a hematologist and oncologist in New York, New York
Dr. Pasmantier practices at Morton Coleman MD And Mark W Pasmantier in New York, New York.
Dr. Pasmantier's NPI, 1558430199, was assigned on November 7, 2006. Dr. Pasmantier graduated from New York University School of Medicine in 1966. Dr. Pasmantier holds New York license 98988.
NPI and contact details
- NPI
- 1558430199NPI Registry (opens in a new tab)
- NPI enumeration date
- November 7, 2006
- NPI status
- Active
- Practice phone
- (212) 517-5900
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 86
- Medical school graduation
- 1966
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark W. Pasmantier practices at 2 locations in New York, New York
Dr. Pasmantier's primary practice is Morton Coleman MD and Mark W Pasmantier, at 407 E 70th St, New York, NY 10021-5311. The practice phone is (212) 517-5900. The NPI Registry lists Dr. Pasmantier's practice address as 525 E 68th St, New York, NY 10065.
- Morton Coleman MD and Mark W PasmantierPrimary407 E 70th St, New York, NY 10021-5311Phone(212) 517-5900
- NPI Registry address525 E 68th St, New York, NY 10065 · New York CountyPhone(212) 517-5900
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. Mark W. Pasmantier is affiliated with 2 sites of care and 2 medical groups
Dr. Pasmantier's primary practice is Morton Coleman MD And Mark W Pasmantier in New York, New York. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Pasmantier to 1 more group practice or clinic and 1 medical group, each named with a free account.
Morton Coleman MD And Mark W PasmantierPrimary
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Mark W. Pasmantier's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasmantier practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Morton Coleman MD And Mark W Pasmantier | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Pasmantier practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark W. Pasmantier is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Pasmantier's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pasmantier is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Pasmantier
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark W. Pasmantier billed Medicare for 8,320 services in 2022
CMS data shows 8,320 Medicare services from Dr. Pasmantier across 29 procedure codes in 2022. Medicare paid $109,703 for them. Every service was in an office.
Medicare services, 20228,320
Paid by Medicare$109,703
Procedure codes29
Dr. Pasmantier's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Drugs given in the office
- 2021: 2,8162022: 2,6496%
- Lab and pathology
- 2021: 3,0362022: 1,70544%
- Other services
- 2021: 1,9492022: 1,67614%
- Surgery
- 2021: 1,2242022: 1,01317%
- Tests and treatments
- 2021: 1,0092022: 79521%
- Office and hospital visits
- 2021: 7292022: 48234%
Dr. Pasmantier compared with the New York median for hematologists and oncologists, 2022
- Dr. Pasmantier
- New York median
- Medicare services
- 8,320vs 66812.5 times
- Part D claims
- 162vs 25837% below
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Pasmantier's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Pasmantier?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pasmantier and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark W. Pasmantier's patients have a median age of 81
Across all payers, Dmand AI patient panel data puts Dr. Pasmantier's median patient age at 81, with 85% women.
Dr. Pasmantier's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 81
Patient panel by sex, all payers
- Women85%
- Men15%
Source: Dmand AI Patient Panel Data
Dr. Mark W. Pasmantier wrote 24 Medicare Part D claims in 2024
In 2024, Dr. Pasmantier wrote 24 Medicare Part D claims. 88% of them were for generic drugs. They cover 10 drugs, with $13,279 in total drug cost. In 2022, CMS named 1,092 claims across 45 drugs.
Part D claims, 202424
Drugs named by CMS10
Total drug cost$13,279
Dr. Pasmantier's Part D claims by kind of drug, 2024
- Generic21 claims88%
- Brand-name and other3 claims13%
Dr. Pasmantier's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 1,0922023: 16285%
Drugs named by CMS: 10 in 2023, 45 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Pasmantier by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark W. Pasmantier has 4 publications on record
Dmand AI links 4 papers to Dr. Pasmantier, published from 2010 to 2012. 2012 was the busiest year, with 2. The most frequent topics are Lung Neoplasms and Tomography, X-Ray Computed. Dr. Pasmantier's most frequent co-authors are Daniel Miles Libby, MD, Thomas A. Caputo, MD and Melissa Kristen Frey, MD.
Papers4
Years published2010 to 2012
Dr. Pasmantier's papers by year, 2010 to 2012
Topics Dr. Pasmantier writes about most
- Lung Neoplasms
- Tomography, X-Ray Computed
Dr. Pasmantier's most frequent co-authors
- Daniel Miles Libby, MD3 shared papers
- Thomas A. Caputo, MD1 shared paper
- Melissa Kristen Frey, MD1 shared paper
Recent publications by Dr. Pasmantier
Chi-Square DistributionLung NeoplasmsMass Screening
Cause of DeathImage Interpretation, Computer-AssistedLung Neoplasms
See who Dr. Pasmantier researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pasmantier works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark W. Pasmantier has worked on 1 clinical trial
Dmand AI links Dr. Pasmantier to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.
Conditions in Dr. Pasmantier's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Pasmantier
Recent clinical trials with Dr. Pasmantier
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer (opens in a new tab)
Active, not recruiting
Carcinoma, Non-Small-Cell LungCarcinoma, Bronchogenic
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mark W. Pasmantier received $1,901 in industry payments from 2016 to 2021
CMS Open Payments shows 95 general payments to Dr. Pasmantier from 15 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $612.
General payments to Dr. Pasmantier by program year, 2016 to 2021
General payments to Dr. Pasmantier by kind, 2016 to 2021
$1.9Kin total
- Food and beverage$1,74192%
- Education$1608%
Companies that paid Dr. Pasmantier the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark W. Pasmantier graduated from New York University School of Medicine
Dr. Pasmantier graduated from New York University School of Medicine in 1966.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark W. Pasmantier's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark W. Pasmantier
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark W. Pasmantier's NPI number?
Dr. Mark W. Pasmantier's NPI number is 1558430199. It was assigned on November 7, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark W. Pasmantier?
Dr. Mark W. Pasmantier is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mark W. Pasmantier practice?
Dr. Pasmantier practices at 407 E 70th St, New York, NY 10021-5311. Dr. Pasmantier also practices at 525 E 68th St, New York, NY 10065. Dr. Pasmantier's primary practice is Morton Coleman MD And Mark W Pasmantier in New York, New York. Dmand AI also links Dr. Pasmantier to 1 group practice or clinic and 1 medical group.
What is Dr. Mark W. Pasmantier's office phone number?
The practice phone on file for Dr. Pasmantier is (212) 517-5900.
What is Dr. Mark W. Pasmantier's medical license number?
Dr. Pasmantier holds New York license 98988.
What medical group is Dr. Mark W. Pasmantier part of?
Dr. Pasmantier is linked to Weill Cornell Physicians. Dmand AI links Dr. Pasmantier to 1 more medical group.
Does Dr. Mark W. Pasmantier accept Medicare?
Yes. CMS data shows Dr. Pasmantier billed Medicare for 8,320 services in 2022.
What services does Dr. Mark W. Pasmantier bill to Medicare?
In 2022, Dr. Pasmantier's most billed Medicare services were injected or infused drug (J1100), medicare temporary code (Q5106) and surgery: heart and blood vessels (36415).
Where did Dr. Mark W. Pasmantier go to medical school?
Dr. Pasmantier graduated from New York University School of Medicine in 1966.
What drugs does Dr. Mark W. Pasmantier prescribe most?
In 2023 Medicare Part D data, Dr. Pasmantier's most prescribed drugs by claims were Anastrozole, Hydrochlorothiazide and Valacyclovir.
Show 4 more questionsShow fewer questions
Has Dr. Mark W. Pasmantier received payments from drug or device companies?
CMS Open Payments shows $1,901 in general payments to Dr. Pasmantier from 15 companies from 2016 to 2021. The largest total came from Amgen Inc.
How long has Dr. Mark W. Pasmantier been practicing?
Dr. Pasmantier graduated from medical school in 1966, 60 years ago.
Does Dr. Mark W. Pasmantier do research?
Dmand AI links 4 publications to Dr. Pasmantier, published from 2010 to 2012. Dr. Pasmantier has worked on 1 clinical trial.
Who does Dr. Mark W. Pasmantier publish with?
Dr. Pasmantier's most frequent co-authors are Daniel Miles Libby, MD (3 shared papers), Thomas A. Caputo, MD (1 shared paper) and Melissa Kristen Frey, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card